3,357
Views
107
CrossRef citations to date
0
Altmetric
Articles

Efficacy and Safety of Ashwagandha (Withania somnifera (L.) Dunal) Root Extract in Improving Memory and Cognitive Functions

, MD, , MPharm, PhD & , MPharm, PhD

References

  • Aguiar S, Borowski T. Neuropharmacological review of the nootropic herb Bacopa monnieri. Rejuvenation Res. 2013;16:313–326.
  • Department of Ayush. Ayurvedic pharmacopea of India, Vol-1. New Delhi, India: Ministry of Health and Family Welfare, 1989.
  • Baldo JV, Katseff S, Dronkers NF. Brain regions underlying repetition and auditory-verbal short-term memory deficits in aphasia: evidence from voxel-based lesion symptom mapping. Aphasiology. 2012;26:338–354. doi:10.1080/02687038.2011.602391
  • Barcelo F, Sanz M, Molina V, Rubia, F. The Wisconsin card sorting test and the assessment of frontal function: a validation study with event-related potentials. Neuropsychologia. 1997;35:399–408.
  • Barch DM. Pharmacological manipulation of human working memory. Psychopharmacology (Berlin). 2004;174:126–135. doi:10.1007/s00213-003-1732-3
  • Bostrom N, Sandberg A. Cognitive enhancement: methods, ethics, regulatory challenges. Sci Eng Ethics. 2009;15:311–341. doi:10.1007/s11948-009-9142-5
  • Brahmachari G.. Bioactive natural products: opportunities and challenges in medicinal chemistry. Hackensack, NJ: World Scientific. 2011.
  • Chengappa KNR, Bowie CR, Schlicht PJ, Fleet D, Brar JS, Jindal R. Randomized placebo-controlled adjunctive study of an extract of Withania somnifera for cognitive dysfunction in bipolar disorder. J Clin Psychiatry. 2013;74:1076–1083. doi:10.4088/JCP.13m08413
  • Chertkow H. Diagnosis and treatment of dementia: Introduction. Introducing a series based on the Third Canadian Consensus Conference on the Diagnosis and Treatment of Dementia. Can Med Assoc J. 2008;178:316–321.
  • Choudhary MI, Nawaz SA, Lodhi MA, Ghayur MN, Jalil S, Riaz N, et al. Withanolides, a new class of natural cholinesterase inhibitors with calcium antagonistic properties. Biochem Biophys Res Commun. 2005;334:276–287. doi:10.1016/j.bbrc.2005.06.086
  • Choudhary MI, Yousuf S, Nawaz SA, Ahmed S, Atta-ur-Rahman. Cholinesterase inhibiting withanolides from Withania somnifera. Chem Pharm Bull (Tokyo). 2004;52:1358–1361. doi:10.1248/cpb.52.1358
  • Cooper LA. Mental rotation of random two-dimensional shapes. Cogn Psychol. 1975;7:20–43. doi:10.1016/0010-0285(75)90003-1
  • de Graaf TA, Roebroeck A, Goebel R, Sack AT. Brain network dynamics underlying visuospatial judgment: an FMRI connectivity study. J Cogn Neurosci. 2010;22:2012–2026. doi:10.1162/jocn.2009.21345
  • Dhuley JN. Nootropic-like effect of ashwagandha (Withania somnifera L.) in mice. Phytother Res. 2001;15:524–528. doi:10.1002/ptr.2704
  • Eriksen BA, Eriksen CW. Effects of noise letters upon the identification of a target letter in a nonsearch task. Percept Psychophys. 1974;16:143–149.
  • Eysenck MW, Derakshan N, Santos R, Calvo MG. Anxiety and cognitive performance: attentional control theory. Emotion. 2007;7:336–353. doi:10.1037/1528-3542.7.2.336
  • Jelic V, Kivipelto M, Winblad B. Clinical trials in mild cognitive impairment: lessons for the future. J Neurol Neurosurg Psychiatry. 2006;77:429–438. doi:10.1136/jnnp.2005.072926
  • Jelic V, Winblad B. Treatment of mild cognitive impairment: rationale, present and future strategies. Acta Neurol Scand Suppl. 2003;179:83–93.
  • Kaschel R. Ginkgo biloba: specificity of neuropsychological improvement; a selective review in search of differential effects. Hum Psychopharmacol. 2009;24(5):45–370. doi:10.1002/hup
  • Kennedy DO, Wightman EEL. Herbal extracts and phytochemicals: plant secondary metabolites and the enhancement of human brain function. Adv Nutr Ann. 2011;2:32–50. doi:10.3945/an.110.000117.32
  • Kivimäki M, Lusa S. Stress and cognitive performance of fire fighters during smoke-diving. Stress Med. 1994;10:63–68. doi:10.1002/smi.2460100111
  • Kuboyama T, Tohda C, Komatsu K. Effects of ashwagandha (roots of Withania somnifera) on neurodegenerative diseases. Biol. Pharm. Bull. 2014;37:892–897.
  • Kurapati KRV., Atluri VSR, Samikkannu T, Nair MPN.. Ashwagandha (Withania somnifera) reverses β-Amyloid1-42 induced toxicity in human neuronal cells: implications in HIV-associated neurocognitive disorders (HAND). PLoS One. 2013;8:1–15. doi:10.1371/journal.pone.0077624
  • Lichstein KL, Riedel BW, Richman SL. The Mackworth clock test: a computerized version. J Psychol. 2000;134:153–161. doi:10.1080/00223980009600858
  • Mackenzie CS, Smith MC, Hasher L, Leach L, Behl P. Cognitive functioning under stress: evidence from informal caregivers of palliative patients. J Palliat Med. 2007;10:749–758. doi:10.1089/jpm.2006.0171
  • McEwen BS., Sapolsky RM.. Stress and cognitive function. Curr Opin Neurobiol. 1995;5:205–216. doi:10.1016/0959-4388(95)80028-X
  • Miller MA. The role of sleep and sleep disorders in the development, diagnosis, and management of neurocognitive disorders. Front Neurol. 2015;6:244.
  • Miroddi M, Navarra M, Quattropani MC, Calapai F, Gangemi S, Calapai G. Systematic review of clinical trials assessing pharmacological properties of Salvia species on memory, cognitive impairment and Alzheimer's disease. CNS Neurosci Ther. 2014;20:485–495. doi:10.1111/cns.12270
  • Mungas D. In-office mental status testing: a practical guide. Geriatrics. 1991;46:54–58, 63, 66.
  • Nagashayana N, Sankarankutty P, Nampoothiri MRV, Mohan PK, Mohanakumar KP. Association of L-DOPA with recovery following Ayurveda medication in Parkinson's disease. J Neurol Sci. 2000;176:124–127. doi:10.1016/S0022-510X(00)00329-4
  • Naidu, PS, Singh, A, Kulkarni, SK. Effect of Withania somnifera root extract on reserpine-induced orofacial dyskinesia and cognitive dysfunction. Phytother Res. 2006;20:140–146. doi:10.1002/ptr.1823
  • Owen AM. The functional organization of working memory processes within human lateral frontal cortex: the contribution of functional neuroimaging. Eur J Neurosci. 1997;9:1329–1339.
  • Pingali U, Pilli R, Fatima N. Effect of standardized aqueous extract of Withania somnifera on tests of cognitive and psychomotor performance in healthy human participants. Pharmacognosy Res. 2014;6:12–18. doi:10.4103/0974-8490.122912
  • Prakash J, Chouhan S, Yadav SK, Westfall S, Rai SN, Singh SP. Withania somnifera alleviates parkinsonian phenotypes by inhibiting apoptotic pathways in dopaminergic neurons. Neurochem Res. 2014;39:2527–2536. doi:10.1007/s11064-014-1443-7
  • RajaSankar S, Manivasagam T, Sankar V, Prakash S, Muthusamy R, Krishnamurti A, Surendran S. Withania somnifera root extract improves catecholamines and physiological abnormalities seen in a Parkinson's disease model mouse. J Ethnopharmacol. 2009;125:369–373. doi:10.1016/j.jep.2009.08.003
  • Schliebs R, Liebmann A, Bhattacharya S, Kumar A, Ghosal S, Bigl V. Systemic administration of defined extracts from Withania somnifera (Indian ginseng) and Shilajit differentially affects cholinergic but not glutamatergic and GABAergic markers in rat brain. Neurochem Int. 1997;30:181–190. doi:10.1016/S0197-0186(96)00025-3
  • Sehgal N, Gupta A, Valli RK, Joshi SD, Mills JT, Hamel E, et al. Withania somnifera reverses Alzheimer's disease pathology by enhancing low-density lipoprotein receptor-related protein in liver. Proc Natl Acad Sci USA. 2012;109:3510–3515. doi:10.1073/pnas.1112209109
  • Singh RH, Narsimhamurthy K, Singh G. Neuronutrient impact of Ayurvedic Rasayana therapy in brain aging. Biogerontology. 2008;9:369–374. doi:10.1007/s10522-008-9185-z
  • Singh RH., Udupa KN. Clinical and experimental studies on Rasayana drugs and Rasayana therapy. New Delhi, India: Spec. Res. Monogr. Central Council of Research, Ayurveda Siddha (CCRAS), Ministry of Health and Family Welfare, 1993.
  • Singh-Manoux A, Kivimaki M, Glymour MM, Elbaz A, Berr C, Ebmeier KP, et al. Timing of onset of cognitive decline: results from Whitehall II prospective cohort study. Brit Med J. 2012;344:d7622. doi:10.1136/bmj.d7622
  • Todd JJ, Marois R. Capacity limit of visual short-term memory in human posterior parietal cortex. Nature. 2004;428:751–754. doi:10.1038/nature02466
  • Tombaugh TN. Trail making test A and B: Normative data stratified by age and education. Arch Clin Neuropsychol. 2004;19:203–214. doi:10.1016/S0887-6177(03)00039-8
  • Ven Murthy MR, Ranjekar KP, Ramassamy C, Deshpande M. Scientific basis for the use of Indian Ayurvedic medicinal plants in the treatment of neurodegenerative disorders: 1. Ashwagandha. Cent. Nerv. Syst. Agents Med. Chem. 2010;10:238–246.
  • Verma SK, Kumar A. Therapeutic uses of Withania somnifera (Ashwagandha) with a note on withanolides and its pharmacological actions. Asian J Pharm Clin Res. 2011;4(1):1–4.
  • Vinutha B, Prashanth D, Salma K, Sreeja SL, Pratiti D, Padmaja R, et al. Screening of selected Indian medicinal plants for acetylcholinesterase inhibitory activity. J Ethnopharmacol. 2007;109:359–363. doi:10.1016/j.jep.2006.06.014
  • Wechsler D, Gurappa P. WMS-III India: Wechsler memory scale (3rd Ed.). Bangalore, India: The Psychological Corporation, 2009.
  • Wechsler D, Scale WM. WMS-III. Wechsler memory scale (3rd Ed.). San Antonio, TX: Psychol. Corp, 1997.
  • World Health Organization (WHO). WHO monographs on selected medicinal plants, Vol. 4. Geneva, Switzerland: World Health Organization, 2009.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.